Why is Transgene Biotek falling/rising?

As of 06-Nov, Transgene Biotek Ltd's stock price is currently at Rs 3.36, reflecting a decline of Rs 0.22 or 6.15%. The stock has been underperforming, having lost 11.58% over the last two days and is trading below all key moving averages, indicating a bearish trend. Additionally, it is 4.46% away from its 52-week low of Rs 3.21. In terms of performance relative to the benchmark, the stock has seen significant declines, with a year-to-date drop of 50.81%, while the Sensex has gained 6.62% during the same period. Although there has been a notable increase in investor participation, with delivery volume rising by 79.97% against the 5-day average, the overall sentiment remains negative.
Broader Market Context: In the short term, Transgene Biotek's performance has been markedly worse than the Sensex, which has only declined by 1.30% over the past week, while Transgene Biotek has dropped by 10.16%. This stark contrast highlights the stock's struggles in a broader market that has shown resilience. The negative performance over various time frames, including a 50.95% decline over the past year, further emphasizes the challenges faced by the company in attracting investor confidence compared to the overall market trends.